HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masatoshi Tagawa Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

1/2017Augmented expression of cardiac ankyrin repeat protein is induced by pemetrexed and a possible marker for the pemetrexed resistance in mesothelioma cells.
11/2011Antitumor activity of type III interferon alone or in combination with type I interferon against human non-small cell lung cancer.
9/2004Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masatoshi Tagawa Research Topics

Disease

68Neoplasms (Cancer)
08/2021 - 01/2002
19Mesothelioma
01/2020 - 08/2010
16Carcinoma (Carcinomatosis)
01/2019 - 01/2002
10Malignant Mesothelioma
01/2017 - 01/2008
9Pancreatic Neoplasms (Pancreatic Cancer)
10/2017 - 01/2002
8Infections
11/2017 - 06/2007
6Hepatocellular Carcinoma (Hepatoma)
01/2019 - 06/2002
6Lung Neoplasms (Lung Cancer)
01/2016 - 07/2004
4Esophageal Neoplasms (Esophageal Cancer)
01/2016 - 07/2003
4Ovarian Neoplasms (Ovarian Cancer)
02/2012 - 05/2003
3Stomach Neoplasms (Stomach Cancer)
03/2017 - 11/2006
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2017 - 09/2004
3Breast Neoplasms (Breast Cancer)
01/2016 - 03/2002
3Urinary Bladder Neoplasms (Bladder Cancer)
04/2013 - 07/2004
3Brain Neoplasms (Brain Tumor)
05/2005 - 12/2002
2Colorectal Neoplasms (Colorectal Cancer)
10/2018 - 01/2016
2Adenocarcinoma
10/2017 - 09/2004
2Pleurisy (Pleuritis)
01/2017 - 01/2013
2Neuroblastoma
09/2016 - 08/2003
2Prostatic Neoplasms (Prostate Cancer)
01/2016 - 07/2004
2Carcinogenesis
09/2005 - 01/2005
2Neoplasm Metastasis (Metastasis)
09/2004 - 05/2002
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2004 - 05/2003
2Glioma (Gliomas)
07/2004 - 08/2003
2Gliosarcoma
08/2003 - 12/2002
1Dyspnea (Shortness of Breath)
01/2020
1Virus Diseases (Viral Diseases)
11/2017
1Primitive Neuroectodermal Tumors (PNET)
10/2017
1Pleural Diseases
01/2017

Drug/Important Bio-Agent (IBA)

18MidkineIBA
09/2017 - 01/2002
11Proteins (Proteins, Gene)FDA Link
11/2017 - 10/2002
10CytokinesIBA
02/2012 - 06/2003
7DNA (Deoxyribonucleic Acid)IBA
01/2019 - 05/2003
7EnzymesIBA
01/2019 - 07/2003
7SurvivinIBA
10/2017 - 07/2003
7adenovirus receptorIBA
11/2013 - 07/2004
7Messenger RNA (mRNA)IBA
04/2013 - 07/2004
7Interleukin-23 (Interleukin 23)IBA
03/2008 - 07/2003
6Cyclooxygenase 2 (Cyclooxygenase-2)IBA
09/2017 - 05/2003
6Cisplatin (Platino)FDA LinkGeneric
01/2016 - 01/2010
5ProdrugsIBA
01/2019 - 01/2002
5InterleukinsIBA
11/2014 - 10/2003
5Interferon LambdaIBA
01/2013 - 01/2010
5Interleukin-12 (IL 12)IBA
03/2008 - 01/2002
5CD40 Ligand (CD40L)IBA
03/2008 - 06/2003
5Fas Ligand Protein (Fas Ligand)IBA
01/2005 - 03/2002
4AsbestosIBA
01/2020 - 01/2008
4Pemetrexed (MTA)FDA Link
01/2019 - 07/2012
4AutoantibodiesIBA
10/2018 - 01/2016
4LuciferasesIBA
09/2017 - 08/2008
4Biomarkers (Surrogate Marker)IBA
01/2017 - 09/2005
4Zoledronic Acid (Zometa)FDA Link
12/2016 - 05/2012
4Diphosphonates (Bisphosphonates)IBA
12/2016 - 05/2012
4Ganciclovir (Cytovene)FDA LinkGeneric
08/2010 - 01/2002
4Interleukin-2 (IL2)IBA
05/2005 - 01/2002
3Neoplasm Antigens (Tumor Antigens)IBA
10/2018 - 11/2006
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2018 - 07/2003
3LigandsIBA
10/2017 - 10/2014
3ImmunosorbentsIBA
01/2016 - 07/2003
3CaspasesIBA
06/2015 - 05/2012
3Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
02/2012 - 08/2003
3Interleukin-27 (Interleukin 27)IBA
03/2008 - 11/2004
3Thymidine KinaseIBA
01/2007 - 01/2002
3Interferon-gamma (Interferon, gamma)IBA
06/2005 - 03/2003
3interleukin-21 (interleukin 21)IBA
01/2004 - 03/2003
2CP 31398IBA
01/2020 - 01/2019
2nutlin 3IBA
01/2020 - 01/2017
2RNA (Ribonucleic Acid)IBA
01/2019 - 01/2017
2Caspase 3 (Caspase-3)IBA
11/2017 - 01/2010
2Peptides (Polypeptides)IBA
10/2017 - 10/2014
2AntigensIBA
03/2017 - 01/2008
2Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
01/2015 - 12/2010
2CarcinogensIBA
09/2014 - 11/2006
2Therapeutic UsesIBA
01/2013 - 05/2003
2Antineoplastic Agents (Antineoplastics)IBA
01/2013 - 12/2012
2Neutralizing AntibodiesIBA
02/2012 - 06/2007
2Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
12/2010 - 09/2005
2Indicators and Reagents (Reagents)IBA
11/2010 - 09/2004
2Fluorouracil (Carac)FDA LinkGeneric
01/2010 - 11/2006
2DNA-Directed DNA Polymerase (Polymerases, DNA)IBA
01/2005 - 07/2004
2VaccinesIBA
08/2003 - 09/2002
2ElementsIBA
05/2003 - 03/2002
2CCAAT-Enhancer-Binding Protein-alphaIBA
01/2003 - 06/2002
1Codon (Codons)IBA
08/2021
170-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA
01/2019
1pyrimidineIBA
01/2019
1purineIBA
01/2019
1YY1 Transcription FactorIBA
01/2019
1Annexin A2 (Annexin II)IBA
10/2018
117- (dimethylaminoethylamino)- 17- demethoxygeldanamycinIBA
05/2018
1HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
03/2017
1Peroxiredoxin VIIBA
03/2017
1Metformin (Glucophage)FDA LinkGeneric
01/2017
1Epithelial Cell Adhesion MoleculeIBA
01/2017
1MesothelinIBA
01/2017

Therapy/Procedure

12Therapeutics
10/2017 - 05/2003
5Drug Therapy (Chemotherapy)
01/2016 - 11/2006
3Oncolytic Virotherapy
10/2014 - 08/2010
2Radiotherapy
01/2008 - 11/2006
1Local Anesthesia
01/2020